EsSalud Implements Centralized Planning to End Hospital Supply Shortages
EsSalud has established a specialized multidisciplinary team to centralize the annual acquisition of pharmaceuticals, medical devices, and strategic supplies. The structural overhaul aims to dismantle a reactive, fragmented purchasing model that left clinical networks without essential supplies over an eight-month period, triggering severe logistical strain and a 68% occupancy rate in the central warehouse.
- EsSalud enacted General Management Resolution N.° 001828-GG-ESSALUD-2026 to create a centralized planning task force.
- The agency authorized an immediate, extraordinary local purchase of 924 items to mitigate active stockout risks across national networks.
- The new procurement framework links demand forecasting, inventory levels, active contracts, and storage capacity to prevent future supply bottlenecks.
Transitioning From Reactive Purchasing to Centralized Supply Chain Governance
For the past eight months, the public healthcare system operated without the requisite central procurement cycles. Clinical networks were forced to resolve urgent deficits through decentralized, small-volume acquisitions starting in June. This decentralized approach bypassed unified scheduling, severely eroding the institution’s predictive capacity and creating immense logistical friction. The central warehouse operator recorded an extraordinary 68% capacity utilization, struggling to intake incoming lots due to the lack of an articulated intake calendar.
To resolve this systemic vulnerability, Minister of Labor and Employment Promotion Juan Sheput coordinated with Executive President in charge Hilda Sandoval Cornejo to establish the specialized working group. This body brings together delegates from the General Management, the Central Supply Agency for Strategic Goods, the Central Operations Management, the Institute for Health Technology Assessment and Research, the Central Logistics Management, and the Almenara, Rebagliati, and Sabogal health networks.
Emergency Procurements and Immediate Stock Mitigation
While long-term annual planning is phased into operation, EsSalud authorized immediate stopgap measures under Resolutions N.° 000079 and N.° 000080-CEABE-ESSALUD-2026. These directives greenlit the local acquisition of 924 strategic items to protect patient safety and maintain continuity of care. The emergency authorization covers 502 pharmaceutical products alongside 422 medical, radiological, and laboratory reagent items.
Decentralized operational units and national providers must officially report these local acquisitions and substantiate resource allocation under strict administrative and functional accountability. By enforcing these bounds, local purchases return to their intended status as exceptional measures rather than routine reactions to systemic planning failures.
Diagnostic Gap Analysis and Future Logistics Architecture
The newly formed task force carries a broad mandate encompassing baseline diagnostics, gap identification, demand quantification, and delivery schedule optimization. By replacing ad-hoc emergency buying with data-driven consumption modeling, the institution aims to align procurement volumes with true epidemiological demand across each provider network.
The ultimate success of this centralized model depends on active early-warning indicators and robust inventory synchronization. As the agency deploys these parameters, administrators will continue monitoring storage capacity metrics to prevent both acute stockouts and redundant product accumulation across central and peripheral depots.
*Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.*